Issue Date | Title | Involved Person(s) |
2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
2-Dec-2023 | Wirksamkeitsforschung heute : das Beispiel Depressionsbehandlungen | Hengartner, Michael Pascal |
Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
14-Feb-2022 | Opinion: Regulators are approving drugs without clear evidence that they work | Hengartner, Michael Pascal |
2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
Dec-2021 | Evidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interest | Hengartner, Michael P. |
8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
Aug-2020 | Antidepressiva gegen Depressionen : aktuelle Kontroversen um Nutzen und Risiken | Hengartner, Michael Pascal |